IRIS
SORRENTINO, Dario Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.321
AS - Asia 4.087
EU - Europa 2.672
SA - Sud America 719
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 3
Totale 17.893
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.205
SG - Singapore 2.060
CN - Cina 913
UA - Ucraina 781
BR - Brasile 566
DE - Germania 532
HK - Hong Kong 390
FI - Finlandia 350
VN - Vietnam 285
SE - Svezia 190
RU - Federazione Russa 178
FR - Francia 169
IT - Italia 145
IE - Irlanda 144
TR - Turchia 111
IN - India 82
GB - Regno Unito 74
CA - Canada 68
AR - Argentina 53
BD - Bangladesh 39
KR - Corea 37
NL - Olanda 29
EC - Ecuador 26
IQ - Iraq 26
MX - Messico 23
VE - Venezuela 21
ID - Indonesia 20
PL - Polonia 20
ZA - Sudafrica 18
CL - Cile 17
IR - Iran 16
CO - Colombia 15
JP - Giappone 14
BE - Belgio 13
PK - Pakistan 13
TN - Tunisia 13
ES - Italia 11
KE - Kenya 11
EU - Europa 10
PY - Paraguay 10
MA - Marocco 9
SA - Arabia Saudita 9
AT - Austria 8
EG - Egitto 8
JO - Giordania 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
NP - Nepal 6
PE - Perù 6
AZ - Azerbaigian 5
ET - Etiopia 5
UZ - Uzbekistan 5
AL - Albania 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
NI - Nicaragua 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
KZ - Kazakistan 3
PA - Panama 3
QA - Qatar 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
LB - Libano 2
LT - Lituania 2
MY - Malesia 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
UY - Uruguay 2
AD - Andorra 1
AO - Angola 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
CU - Cuba 1
EE - Estonia 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KI - Kiribati 1
KW - Kuwait 1
LC - Santa Lucia 1
LV - Lettonia 1
MG - Madagascar 1
MK - Macedonia 1
MZ - Mozambico 1
Totale 17.881
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.394
Fairfield 1.206
Singapore 852
Houston 824
Ashburn 752
Ann Arbor 640
Seattle 506
Jacksonville 499
Chandler 496
Wilmington 468
Dearborn 417
Beijing 412
Cambridge 406
Hong Kong 385
Munich 202
Boardman 186
San Jose 152
Princeton 146
Dublin 143
Helsinki 129
Lauterbourg 129
Izmir 87
Los Angeles 87
Ho Chi Minh City 76
Hefei 72
San Diego 69
Buffalo 65
Hanoi 61
Roanoke 61
Dallas 58
Udine 54
Des Moines 45
Council Bluffs 44
The Dalles 43
Nanjing 39
Redondo Beach 39
São Paulo 39
Dong Ket 36
Seoul 35
New York 34
Kunming 30
Ottawa 29
Norwalk 28
Ogden 28
Orem 26
Mumbai 25
Santa Clara 25
Jinan 24
Rio de Janeiro 22
Guangzhou 20
Atlanta 18
Warsaw 18
Curitiba 16
Nanchang 15
Redmond 15
Toronto 15
Campinas 13
Torre Del Greco 13
Turku 13
Andover 12
Belo Horizonte 12
Brussels 12
Falls Church 12
Haiphong 12
Phoenix 12
Thái Bình 12
Tokyo 12
Brasília 11
Dhaka 11
Grafing 11
Montreal 11
Quito 11
Guayaquil 10
Milan 10
Chicago 9
Frankfurt am Main 9
London 9
Redwood City 9
Boston 8
Brooklyn 8
Chennai 8
Da Nang 8
Fuzhou 8
Hải Dương 8
Johannesburg 8
Moscow 8
Nairobi 8
Nuremberg 8
Porto Alegre 8
Salvador 8
Stockholm 8
Amman 7
Ankara 7
Baghdad 7
Changsha 7
Goiânia 7
Rosendaal 7
San Francisco 7
Shenzhen 7
Simi Valley 7
Totale 12.155
Salva come PNG Salva come JPEG
Nome #
Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study. 317
Mechanisms of cellular uptake of free fatty acids 261
Cavernous transformation of the portal vein associated to multiorgan developmental abnormalities 232
Letter: when to withhold anti-TNF agents prior to abdominal surgery in patients with Crohn's disease—the jury might still be out 226
B-cell clonal expansion in gastric biopsies of patients with dyspepsia and autoimmune diseases: effect of H. Pylori eradication. 199
Bringing Top-End Endoscopy to Regional Australia: Hurdles and Benefits 194
"Albumin Receptor" uptake kinetics do not require an intact lobular architecture and are not specific for albumin 189
Ustekinumab as induction and maintenance therapy for ulcerative colitis 175
At physiologic albumin:oleate concentrations oleate uptake by isolated hepatocytes, adipocytes and cardiac myocytes is a saturable function of unbound oleate concentrations. Uptake kinetics are consistent with the conventional theory 174
Acute severe colitis: infliximab and/or cyclosporine? 173
B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma 173
Infliximab in Crohn's disease: a look at the (not so distant) future. 172
Prevention of postoperative recurrence of Crohn's disease: does the type of surgery matter? 171
Functional and morphological features of isolated hepatocytes preserved in University of Wisconsin solution. 170
Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease 169
Hepatocellular 22Na+ uptake: effect-of-oleate 168
B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome 168
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome 168
Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record? 167
Transferrin metabolism in alcoholic liver disease. 166
Phenobarbital specifically increases the hepatocellular uptake of sulfobromophthalein-glutathione. 164
Anti-TNF's for Postoperative Recurrence in Crohn's Disease: The If's and How's 163
Postoperative recurrence of Crohn's disease: the beginning of the end? 163
Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet 162
Hepatocellular fatty acid uptake is mediated by a plasma membrane fatty acid binding protein closely related to mitochondrial glutamic oxaloacetic transaminase. 161
Bile acid secretion and pool size during phenobarbital-induced hypercholeresis 159
Surgery for Crohn's disease and anti-TNF agents. The changing scenario 157
"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy 156
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 156
An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients 156
The race for mainstream gastrointestinal endoscopy: frontrunners. 155
Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease 155
Fibrocytes, Inflammation, and Fibrosis in Crohn's Disease: Another Piece of the Puzzle. 154
Oleate uptake by isolated hepatocytes and the perfused rat liver is competitively inhibited by palmitate 154
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus 153
Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. 153
The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver 152
Low dose infliximab for prevention of postoperative recurrence of crohn's disease: Long term follow-up and impact of infliximab trough levels and antibodies to infliximab 152
Uptake of oleate by isolated rat adipocytes is mediated by a 40 kDa plasma membrane fatty acid binding protein closely related to that in liver and gut 151
Diagnosis and assessment of Crohn's disease: the present and the future 151
Internet use among inflammatory bowel disease patients: an Italian multicenter survey. 150
Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43 kDa plasma membrane fatty acid binding protein 149
Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort 149
Isolated Bilateral Gastrocnemius Myositis in Crohn Disease Successfully Treated with Adalimumab 149
Hepatic disposition of clinically useful 5-nitrofurans 148
Prevention of postoperative recurrence of Crohn's disease by infliximab 148
B-cell clonality in gastric mucosa of patients with Sjögren's syndrome and connective tissue diseases: relationship with Helicobacter pylori, EBV and human herpesvirus-6 (HHV-6) infections. 147
The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease. 147
Unbound ligand drives hepatocyte taurocholate and BSP uptake at physiological albumin concentration 146
Ustekinumab as induction and maintenance therapy for Crohn's disease 146
Ustekinumab induction and maintenance therapy in refractory Crohn's disease. 145
Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease 144
Medical prevention of postoperative recurrence of Crohn’s Disease: The state of the art 142
Mechanistic aspects of hepatic bilirubin uptake 142
Transmembrane TNF-α density, but not soluble TNF-α level, is associated with primary response to infliximab in inflammatory bowel disease 142
Sex differences in hepatic fatty acid uptake reflect a greater affinity of the transport system in females 140
Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science 140
Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related 139
Therapeutic Targets in Inflammatory Bowel Disease: Are We Getting the Point Across? 138
B-CELL CLONAL EXPANSION IN GASTRIC BIOPSIES OF PATIENTS WITH DYSPEPSIA AND AUTOIMMUNE-DISEASES - EFFECT OF HELICOBACTER-PYLORI ERADICATION 137
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 137
Isolation and partial characterization of plasma membrane fatty acid binding proteins from myocardium and adipose tissue and their relationship to analogous proteins in liver and gut 136
Oleate uptake kinetics in the perfused rat liver are consistent with pseudofacilitation by albumin 136
Esophageal ulceration due to alendronate 136
Organic anion-transporting polypeptides: expression cloning and functional tests 136
Diagnostic and Therapeutic Delays in the Management of Postoperative Crohn's Disease 136
Characteristics of oleate binding to liver plasma membranes and its uptake by isolated hepatocytes 136
The hepatocellular uptake of free fatty acids is selectively preserved during starvation 135
Scientific publications in gastroenterology and hepatology in Western Europe, USA and Japan in the years 1992-1996: a global survey 135
Long-term prevention of postoperative Crohn's disease recurrence with azathioprine: the wolf in the sheep clothing. 134
235) La terapia con Infliximab più Metotrexate a basse dosi nella prevenzione delle recidive post-chirurgiche del Morbo diCrohn 133
Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn's Disease: Partial Benefit by Infliximab-A Pilot Study 132
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents 132
Microbial dysbiosis in spouses of ulcerative colitis patients: Any clues to disease pathogenesis? 132
MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum 132
Heart-touching Chilaiditi's syndrome 131
Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far? 130
Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold? 129
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report. 129
Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale 126
Continuous monitoring of the biliary excretion of a pulse of labeled compounds 125
Familial hyperbilirubinaemia syndromes: kinetic approaches 125
Quantitation of plasma membrane fatty acid binding protein by enzyme dilution and monoclonal antibody based immunoassay 124
Helicobacter pylori infection and autoimmune processes: an emerging field of study. 123
Utility of fecal markers to diagnose and monitor inflammatory bowel diseases 123
Characterization of prelymphomatous stages of lymphoproliferation in Sjögren’s syndrome. 123
The hepatocellular uptake of bilirubin: current concepts and controversies. 120
Small Bowel Inflammation in Crohn's Disease and Other Conditions 120
Gastric B-cell clonal expansion and hepatitis C virus infection: a study in patients with Sjögren’s syndrome. 119
Clinically Significant Small Bowel Crohn's Disease Might Only be Detected by Capsule Endoscopy 116
Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: Kinetic evidence for a high affinity/low capacity sinusoidal membrane system 114
Unexplained Symptoms and Hidden Inflammation in Patients With Crohn's Disease 113
Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease 111
Hepatitis C virus infection and gastric lymphoproliferation in patients with Sjögren's syndrome 110
From albumin to the cytoplasm: the hepatic uptake of organic anions 110
Gastric lymphoid follicles: prevalence in patients with dyspepsia and with autoimmune diseases and relationship with Helicobacter pylori infection. Gastroenterology 108
The Coming of Age of Inflammatory Bowel Diseases in Asia 108
Management of post-operative Crohn’s disease in 2017: where do we go from here? 105
MR of small bowel in patients with Crohn’s disease: Evaluation of inflammatory activity using standard and cine-MR sequences. 104
Low-dose biologics to treat inflammatory bowel disease. Ready for prime time? 104
Totale 14.815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.803
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021331 0 0 0 0 0 0 0 0 0 0 204 127
2021/20221.177 49 120 51 85 35 57 73 62 12 201 216 216
2022/20231.193 165 79 14 136 116 368 10 69 163 13 20 40
2023/2024276 51 29 12 2 50 50 4 21 38 2 7 10
2024/20252.685 29 171 81 38 211 183 199 192 289 242 339 711
2025/20263.848 267 529 382 375 672 320 474 132 222 366 109 0
Totale 18.289